• Disease
  • Life
  • Life Cisplatin
  • Ferdinando Riccardi

    Prominent publications by Ferdinando Riccardi

    KOL Index score: 9575

    Purpose To test the efficacy of adding cisplatin to first-line treatment for elderly patients with advanced non-small-cell lung cancer (NSCLC) within a combined analysis of two parallel phase III trials, MILES-3 and MILES-4. Patients and Methods Patients with advanced NSCLC who were older than age 70 years with Eastern Cooperative Oncology Group performance status 0 to 1 were randomly assigned to gemcitabine or pemetrexed, without or with cisplatin. In each trial, 382 events were ...

    Also Ranks for: Elderly Patients |  cell lung |  joint analysis |  life cisplatin |  advanced nsclc
    KOL Index score: 8628

    PURPOSE: Erlotinib prolonged survival of unselected patients with advanced non-small-cell lung cancer (NSCLC) who were not eligible for further chemotherapy, and two phase II studies suggested it might be an alternative to first-line chemotherapy. A randomized phase III trial was designed to test whether first-line erlotinib followed at progression by cisplatin-gemcitabine was not inferior in terms of survival to the standard inverse sequence.

    PATIENTS AND METHODS: Patients with stage ...

    Also Ranks for: Cell Lung |  experimental arm |  unselected patients |  firstline erlotinib |  terms survival


    Ferdinando Riccardi: Influence Statistics

    Sample of concepts for which Ferdinando Riccardi is among the top experts in the world.
    Concept World rank
    torch randomized #26
    trials miles3 #29
    standard inverse sequence #30
    analysis miles3 #39
    miles3 miles4 #43
    miles4 patients #46
    miles3 #48
    miles4 #49

    Key People For Life Cisplatin

    Top KOLs in the world
    Stein Kaasa
    advanced cancer chronic pain quality life
    David Osoba†
    quality life national cancer institute lung cancer
    Marianne Carol Klee
    sexual function cervical cancer advanced stages
    Bengt Bergman
    lung cancer small cell quality life
    Sam Hjelmeland Ahmedzai
    cancer pain multiple myeloma older people
    Neil K Aaronson
    breast cancer quality life physical exercise

    Ferdinando Riccardi:Expert Impact

    Concepts for whichFerdinando Riccardihas direct influence:Life cisplatin,  Advanced nsclc,  Cell lung,  Experimental arm,  Unselected patients,  Firstline erlotinib,  Miles3 miles4,  Firstline chemotherapy.

    Ferdinando Riccardi:KOL impact

    Concepts related to the work of other authors for whichfor which Ferdinando Riccardi has influence:Cell lung,  Egfr mutations,  Acquired resistance,  Kinase inhibitors,  Nsclc patients,  Epidermal growth,  Carcinoma small.



    Is this your profile? manage_accounts Claim your profile content_copy Copy URL code Embed Link to your profile

    Cesare Gridelli and Paolo Maione, Azienda Ospedaliera (AO) San Giuseppe Moscati, Avellino; Alessandro Morabito, Raffaele Costanzo, Gaetano Rocco, Gennaro Daniele, Maria Carmela Piccirillo, and Francesco Perrone, Istituto Nazionale Tumori, Istituto di